Big Moving Stocks for Nov-10 At The Close

These stocks are posting some big moves for today.

Sophiris Bio Inc (SPHS) < (SPHS) is currently trading at $2.80 + 1.94 (225.09%) on 23,700,229 shares traded. Sophiris Bio Inc (SPHS) < is +418.52% year-to-date, and +4.36% over the last 12 months.

Sophiris Bio Inc is a clinical-stage biopharmaceutical company. The Company is engaged in research and development of products for the treatment of urological diseases. It is currently developing PRX302 for treatment of benign prostatic hyperplasia.

Ocata Therapeutics Inc (OCAT) < (OCAT) is currently trading at $8.44 + 3.98 (89.24%) on 7,249,244 shares traded. Ocata Therapeutics Inc (OCAT) < is +38.59% year-to-date, and +24.12% over the last 12 months.

Ocata Therapeutics Inc is a clinical stage biotechnology company in development & commercialization of Regenerative Ophthalmology therapeutics for Stargardt’s macular degeneration, dry age-related macular degeneration, & myopic macular degeneration.

Global Defense & National Security System Inc (GDEF) < (GDEF) is currently trading at $13.75 + 2.87 (26.38%) on 94,983 shares traded. Global Defense & National Security System Inc (GDEF) < is +33.24% year-to-date, and +33.56% over the last 12 months.

Global Defense & National Security Systems Inc is a blank check development stage company. It is formed for the purpose of acquiring, through a merger, capital stock exchange, and asset acquisition.

SciClone Pharmaceuticals Inc. (SCLN) < (SCLN) is currently trading at $9.79 + 1.80 (22.53%) on 2,119,720 shares traded. SciClone Pharmaceuticals Inc. (SCLN) < is +11.76% year-to-date, and +19.38% over the last 12 months.

SciClone Pharmaceuticals Inc is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders.

Bellicum Pharmaceuticals Inc (BLCM) < (BLCM) is currently trading at $20.03 + 3.27 (19.51%) on 1,882,645 shares traded. Bellicum Pharmaceuticals Inc (BLCM) < is -13.06% year-to-date, and -- over the last 12 months.

Bellicum Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It discovers and develops novel cellular immunotherapies of cancer including both hematological cancers and solid tumors, as well as orphan inherited blood disorders.

TrovaGene Inc. (TROV) < (TROV) is currently trading at $5.29 + 0.6916 (15.03%) on 803,756 shares traded. TrovaGene Inc. (TROV) < is +23.06% year-to-date, and +10.17% over the last 12 months.

TrovaGene Inc is a development stage molecular diagnostic company. It focuses on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring.

Tecogen Inc (TGEN) < (TGEN) is currently trading at $4.02 + 0.51 (14.53%) on 3,551 shares traded. Tecogen Inc (TGEN) < is -22.99% year-to-date, and -38.96% over the last 12 months.

Tecogen Inc manufactures combined heat and power products based on engines fuelled by natural gas. Its products include cogeneration units that supply electricity and hot water; chillers that provide air-conditioning and hot water; and water heaters.

Aclaris Therapeutics Inc (ACRS) < (ACRS) is currently trading at $17.18 + 2.04 (13.47%) on 64,829 shares traded. Aclaris Therapeutics Inc (ACRS) < is -- year-to-date, and -- over the last 12 months.

Aclaris Therapeutics Inc is a clinical stage pharmaceutical company. It is engaged in identifying, developing and commercializing differentiated topical drugs to address unmet needs in dermatology.

Zogenix Inc. (ZGNX) < (ZGNX) is currently trading at $13.37 + 1.46 (12.26%) on 606,541 shares traded. Zogenix Inc. (ZGNX) < is +21.99% year-to-date, and +26.05% over the last 12 months.

Zogenix Inc is a pharmaceutical company engaged in commercializing & developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.

Applied Genetic Technologies Corp (AGTC) < (AGTC) is currently trading at $15.48 + 1.67 (12.09%) on 160,166 shares traded. Applied Genetic Technologies Corp (AGTC) < is -26.36% year-to-date, and -41.03% over the last 12 months.

Applied Genetic Technologies Corp is a clinical-stage biotechnology company. It is developing gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology.

Alex Fredricks

Alex Fredricks

Alex Fredricks has a degree in business and is an avid day-trader. Alex's experience and love for the game of the markets is shown not only in his posts, but the post he helps edit for other authors on our staff.